Nuclear Medicine Equipment by Product Type [SPECT (Standalone and Hybrid), and PET (Standalone and Hybrid)], Application (Neurology, Oncology, Cardiology, and Others), and End User (Hospitals, Imaging Centers, and Academic & Research Institutes)

  • ID: 4176087
  • Report
  • 170 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Bozlu Holding
  • Digirad Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Neusoft Corporation
  • SurgicEye GmbH
  • MORE
Nuclear medicine equipment utilize radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnosis and treat various diseases. These equipment create images by capturing the radiation from these radioactive medicines. This technique is used for early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine immediate response to therapeutic interventions.

The global nuclear medicine equipment market is estimated to reach $2,647 million by 2022 from $2,012 million in 2015, growing at a CAGR of 3.9% from 2016 to 2022. Increase in prevalence of cancer, heart-related diseases, and neurological disorders has given rise to the importance of early disease diagnosis, which is expected to positively impact the market growth. The nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in adoption of nuclear medicine equipment, and emergence of innovative & advanced equipment. However, high cost of these equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth.

The nuclear medicine equipment market is segmented based on product, application, end user, and geography. Based on product, the market is bifurcated into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). SPECT is further segmented into standalone and hybrid SPECT, while PET into standalone and hybrid PET. By application, the market is categorized into cardiology, neurology, oncology, and others. Based on end user, it is classified into hospitals, imaging centers, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).

The key players in the industry have adopted product launch as their key developmental strategy to expand their market foothold. For instance, in November 2016, Philips launched an advanced visual analysis and quantification platform called IntelliSpace Portal 9.0., which assists radiologists to diagnose and monitor the treatment of neurological diseases, such as multiple sclerosis and dementia.

Key market benefits

This report provides a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
Market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, application, end user, and geography.
In-depth analysis based on geography helps in understanding the regional market to assist in strategic business planning.
The recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bozlu Holding
  • Digirad Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Neusoft Corporation
  • SurgicEye GmbH
  • MORE
Chapter: 1 Introduction

1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models

Chapter: 2 Executive Summary

2.1. CXO Perspective

Chapter: 3 Market Overview

3.1. Market Definitions And Scope
3.2. Key Findings

3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies

3.3. Government Regulations

3.3.1. U.S. Fda
3.3.2. Europe Ce Mark
3.3.3. Ministry Of Health, Labor, And Welfare (Mhlw)

3.4. Reimbursement Scenarios
3.5. Clinical Trials
3.6. Market Dynamics

3.6.1. Drivers

3.6.1.1. Rise In Prevalence Of Chronic Diseases
3.6.1.2. Efficient And Convenient Technique
3.6.1.3. Growing Awareness

3.6.2. Restraints

3.6.2.1. Budget Constraints
3.6.2.2. Lack Of Trained Professionals

3.6.3. Opportunities

3.6.3.1. Technological Advancements
3.6.3.2. Development Of Skilled Professionals

Chapter: 4 Global Nuclear Medicine Equipment Market, By Product Type

4.1. Overview
4.2. Market Size And Forecast
4.3. Spect

4.3.1. Key Market Trends
4.3.2. Key Growth Factors And Opportunities
4.3.3. Market Size And Forecast
4.3.4. Standalone Spect

4.3.4.1. Market Size And Forecast

4.3.5. Hybrid Spect

4.3.5.1. Market Size And Forecast

4.4. Pet

4.4.1. Key Market Trends
4.4.2. Key Growth Factors And Opportunities
4.4.3. Market Size And Forecast
4.4.4. Standalone Pet

4.4.4.1. Market Size And Forecast

4.4.5. Hybrid Pet

4.4.5.1. Market Size And Forecast

Chapter: 5 Global Nuclear Medicine Equipment Market, By Application

5.1. Overview
5.2. Market Size And Forecast
5.3. Neurology

5.3.1. Market Size And Forecast

5.4. Oncology

5.4.1. Market Size And Forecast

5.5. Cardiology

5.5.1. Market Size And Forecast

5.6. Others

5.6.1. Market Size And Forecast

Chapter: 6 Nuclear Medicine Equipment Market, By End User

6.1. Overview
6.2. Market Size And Forecast
6.3. Hospitals

6.3.1. Market Size And Forecast

6.4. Imaging Centers

6.4.1. Market Size And Forecast

6.5. Academic And Research Institutes

6.5.1. Market Size And Forecast

Chapter: 7 Global Nuclear Medicine Equipment Market, By Geography

7.1. Overview
7.2. Market Size And Forecast
7.3. North America

7.3.1. Key Market Trends
7.3.2. Key Growth Factors And Opportunities
7.3.3. Market Size And Forecast
7.3.4. U.S.
7.3.5. Canada
7.3.6. Mexico

7.4. Europe

7.4.1. Key Market Trends
7.4.2. Key Growth Factors And Opportunities
7.4.3. Market Size And Forecast
7.4.4. Germany
7.4.5. France
7.4.6. Uk
7.4.7. Italy
7.4.8. Spain
7.4.9. Russia
7.4.10. Rest Of Europe

7.5. Asia-Pacific

7.5.1. Key Market Trends
7.5.2. Key Growth Factors And Opportunities
7.5.3. Market Size And Forecast
7.5.4. Japan
7.5.5. China
7.5.6. Australia
7.5.7. India
7.5.8. Rest Of Asia-Pacific

7.6. Lamea

7.6.1. Key Market Trends
7.6.2. Key Growth Factors And Opportunities
7.6.3. Market Size And Forecast
7.6.4. Brazil
7.6.5. Turkey
7.6.6. Saudi Arabia
7.6.7. Republic Of South Africa
7.6.8. Argentina
7.6.9. Rest Of Lamea

Chapter: 8 Company Profiles

8.1. Koninklijke Philips N.V.

8.1.1. Overview
8.1.2. Operating Business Segments
8.1.3. Business Performance
8.1.4. Key Strategic Moves And Developments

8.2. Siemens Aktiengesellschaft

8.2.1. Overview
8.2.2. Operating Business Segments
8.2.3. Business Performance
8.2.4. Key Strategic Moves And Developments

8.3. General Electric Company

8.3.1. Overview
8.3.2. Operating Business Segments
8.3.3. Business Performance
8.3.4. Key Strategic Moves And Developments

8.4. Digirad Corporation

8.4.1. Overview
8.4.2. Operating Business Segments
8.4.3. Business Performance
8.4.4. Key Strategic Moves And Developments

8.5. Mediso Medical Imaging Systems, Ltd.

8.5.1. Overview
8.5.2. Operating Business Segments
8.5.3. Key Strategic Moves And Developments

8.6. Toshiba Corporation

8.6.1. Overview
8.6.2. Operating Business Segments
8.6.3. Business Performance

8.7. Bozlu Holding

8.7.1. Overview
8.7.2. Key Strategic Moves And Developments

8.8. Neusoft Corporation

8.8.1. Overview
8.8.2. Operating Business Segments
8.8.3. Key Strategic Moves And Developments

8.9. Compaa Mexicana De Radiologa Cgr, S.A. De C.V.

8.9.1. Overview

8.10. Surgiceye Gmbh

8.10.1. Overview
8.10.2. Key Strategic Moves And Developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bozlu Holding
  • Digirad Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Neusoft Corporation
  • SurgicEye GmbH
  • MORE
Nuclear Medicine Equipment Market Report, forecasts that the global market is expected to reach $2,647 million by 2022 from $2,012 million in 2015 with a CAGR of 3.9% from 2016 to 2022. Oncology segment held more than two-thirds share of the global market in 2015.

Nuclear medicine equipment, such as PET/CT and SPECT scans, are used to capture radiation from small amount of radioisotopes that are introduced into the body. These equipment thus help to diagnose diseases and assess the response of treatment provided to the patient. The major factors that drive the market growth are emergence of new and advanced equipment, increase in prevalence of cancer and cardiovascular diseases, rise in investment in modernization of diagnostic imaging centers, and development of radiotracers.

Oncology is anticipated to dominate the global nuclear medicine equipment market throughout the analysis period, owing to the rise in incidence of cancer and increase in awareness about its early diagnosis. Neurology segment has witnessed highest growth rate as these equipment are used to diagnose and assess the treatment response for various neurological disorders such as Alzheimers disease, brain death/injury, vascular dementia, stroke and transient ischemic attack, and others.

Hospitals dominated with around two-fifths of the global market value in 2015, and are expected to continue this trend during the forecast period. The number of patients visiting hospitals is growing to due increase in the occurrence of chronic diseases, which has fueled the market growth for this segment.

North America dominated the market in 2015, and is maintain its position in the future, due to the presence of a large geriatric population, technological advancements, availability of favorable imbursement policies, and affordability to purchase modern and expensive nuclear medicine equipment.

NUCLEAR MEDICINE EQUIPMENT MARKET KEY FINDINGS:

Hybrid PET segment is projected to grow at the highest rate during the analysis period.
Argentina nuclear medicine equipment market is estimated to grow at a CAGR of 6.0%.
Oncology dominated the global nuclear medicine equipment market in 2015.
U.S. was the largest market in 2015, and is projected to maintain its lead until 2022.
Hospitals segment is projected to dominate throughout 2022.

Key players in the global nuclear medicine equipment market include General Electric Company, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Digirad Corporation, Mediso Medical Imaging Systems, Ltd., Toshiba Corporation, Bozlu Holding, Neusoft Corporation, Compaa Mexicana de Radiologa CGR, S.A. de C.V., and SurgicEye GmbH.
Note: Product cover images may vary from those shown
5 of 5
  • General Electric Company
  • Koninklijke Philips N.V.
  • Siemens Aktiengesellschaft
  • Digirad Corporation
  • Mediso Medical Imaging Systems, Ltd.
  • Toshiba Corporation
  • Bozlu Holding
  • Neusoft Corporation
  • Compañía Mexicana de Radiología CGR, S.A de C.V.
  • SurgicEye GmbH
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll